AIC100 CAR T Cells

· AffyImmune Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AIC100 CAR T Cells, covering 2025-03-30 to 2025-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer [Phase 1]